Nexalin Technology, Inc. Common Stock (NXL)
Nexalin Technology, Inc. (NXL) is a healthcare company that develops and markets neurostimulation devices aimed at treating neurological and psychiatric conditions, such as anxiety, depression, and chronic pain. The company's non-invasive, transcranial electrical stimulation devices are designed to provide therapeutic relief through electrical impulses delivered to specific areas of the brain.
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| April 16, 2007 | $0.31 | 2007-03-23 | 2007-03-27 |
| January 16, 2007 | $0.31 | 2007-01-03 | 2007-01-05 |
| October 16, 2006 | $0.31 | 2006-09-28 | 2006-10-02 |
| July 17, 2006 | $0.31 | 2006-06-29 | 2006-07-03 |
| April 17, 2006 | $0.31 | 2006-03-30 | 2006-04-03 |
Dividends Summary
- Nexalin Technology, Inc. Common Stock has issued 14 dividend payments over the past 3 years
- The most recent dividend was paid 6766 days ago, on April 16, 2007
- The highest dividend payed out to investors during this period was $3.00 per share
- The average dividend paid during this period was $0.55 per share.
Company News
Nexalin Technology, a neurostimulation company, will participate in the 2025 Maxim Growth Summit, showcasing its non-invasive brain stimulation technology for mental health treatment.
Shares of Skillsoft Corp. (NASDAQ: SKIL) fell sharply during Tuesday’s session after the company reported mixed fourth-quarter financial results and issued FY25 revenue guidance below estimates. Skillsoft posted adjusted loss of $3.09 per share, versus market estimates of $3.27 per share. The company’s quarterly sales came in at $137.540 mil...
Biotech penny stocks to watch this week. Are they a buy now? The post Best Penny Stocks To Buy Now? 5 Biotech Stocks To Watch This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.